Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
Abstract
In the Steroid EliMination In Rheumatoid Arthritis (SEMIRA) trial, 65% of patients with rheumatoid arthritis (RA) in low disease activity (LDA) on stable biologic therapy successfully tapered glucocorticoids. We aimed to evaluate real‐world rates of glucocorticoid tapering among similar patients in the Veterans Affairs Rheumatoid Arthritis registry.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 25, 2023
- Source ID
- 10.1002/acr2.11584
Entities
People
- Alison Petro
- Beth Wallace
- Brian C Sauer
- Bryant R England
- Gary A. Kunkel
- Grant W Cannon
- Jorge Rojas
- Joshua F Baker
- Punyasha Roul
- Tawnie J. Braaten
- Ted R Mikuls
Organizations
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- Hospital of the University of Pennsylvania
- National Institute of General Medical Sciences
- United States Department of Defense
- University of Michigan
- University of Nebraska Medical Center
- University of Nebraska–Lincoln
- University of Utah
- VA Salt Lake City Healthcare System